CRRVF - CVR Medical Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
0.2788
-0.0056 (-1.9690%)
At close: 3:47PM EST
Stock chart is not supported by your current browser
Previous Close0.2844
Open0.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0000 - 0.0000
52 Week Range
Volume0
Avg. Volume70,657
Market Cap17.572M
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)-0.1300
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Newsfile27 days ago

    CVR Medical Meets Critical Milestone! Deploys Wireless System at Thomas Jefferson University

    Vancouver, British Columbia--(Newsfile Corp. - November 21, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces the full integration of the "Carotid Stenotic Scan (CSS)" wireless device into its late stage, ongoing clinical trials being conducted at Thomas Jefferson University. The wireless system is the key component of the novel device's efficient and user-friendly design. The wireless Intellectual Property in CVR's portfolio fortifies barrier to entry."We have now ...

  • Newsfilelast month

    CVR Medical Teams with Rogan Molding Technologies

    Vancouver, British Columbia--(Newsfile Corp. - November 15, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces partnership with Rogan Molding Technologies. The Northbrook, IL company will be the exclusive manufacturer of the patient-interfacing gel pad for CVR's "Carotid Stenotic Scan (CSS)."Founded in 1934, Rogan Molding Technologies is a staple organization in original equipment manufacturing, and a global leader in the injection molding industry. Being ISO 9001 and 13485 certified, ...

  • Newsfile3 months ago

    CVR Medical Bolsters Finance, Quality Systems with Knisley

    Vancouver, British Columbia--(Newsfile Corp. - September 28, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces the addition of Mr. Tim Knisley as Director of Finance and Controlling. Knisley will spearhead the building of CVR's financial systems as they transition from research and development-based to commercial-ready with the launch of the "Carotid Stenotic Scan (CSS)" device.Mr. Tim Knisley has worked in the medical device industry for over twenty ...

  • Newsfile3 months ago

    CVR Medical Expanding Scope, Executive Board with Chinese Leadership Expansion

    Vancouver, British Columbia--(Newsfile Corp. - September 20, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE:B3BN) (OTCQB: CRRVF) ("CVR Medical") enters discussions with Key Opinion Leaders in the Chinese cardiovascular health industry, with whom the organization intends to extend membership on the executive board to. The medical and business influence of these leaders will spur the growth of international opportunities for CVR and its "Carotid Stenotic Scan (CSS)" device.In addition, CVR announces the recent start of ...

  • Newsfile3 months ago

    CVR Medical Names Alan Langston, Tech Industry Standout, VP of Sales and Marketing

    Vancouver, British Columbia--(Newsfile Corp. - September 14, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces the addition of Mr. Alan Langston to the company's executive staff. Langston assumes the position of Vice President of Sales and Marketing, responsible for creating and implementing market entry strategies for the company's "Carotid Stenotic Scan (CSS)" device.Mr. Langston brings with him a decorated history across a broad spectrum of the tech industry ...

  • Newsfile3 months ago

    CVR Medical Announces Institutional Research Report

    Vancouver, British Columbia--(Newsfile Corp. - September 11, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to announce that an institutional research report has been released by RB Milestone Group, LLC ("RBMG"). The report on CVR Medical titled "Revolutionizing the Vascular Diagnostics Market" can be found on the website at www.CVRMed.com or by contacting Trevor Brucato, Managing Director at RBMG.CVR Medical CEO Peter Bakema, speaking on the publishing ...

  • Newsfile3 months ago

    First Trial Data Report: Positive Findings, High Expectations for CVR Medical

    Vancouver, British Columbia--(Newsfile Corp. - September 7, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") advisory staff member Dr. Phillip J. Bendick, PhD, has released a summarized report on data from the tertiary clinical trials for the "Carotid Stenotic Scan (CSS)" device at Thomas Jefferson University (see press release dated June 29th, 2017). His report views initial evaluations as successful, and confirms the device's value and efficiency.Dr. Bendick's report ...

  • Newsfile4 months ago

    Dr. Phillip Bendick, Preeminent Vascular Sonographer Joins CVR Medical

    Vancouver, British Columbia--(Newsfile Corp. - August 22, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to announce the addition of Dr. Phillip J. Bendick, PhD, to the company's advisory staff. Dr. Bendick, a renowned medical sonographer and researcher, will assist CVR in the organization of expanded clinical trials for the "Carotid Stenotic Scan (CSS)" device. Dr. Bendick will bring a wealth of knowledge and an extensive ...

  • Newsfile4 months ago

    Stroke Prevention Makes Quantum Leap into the Future: CVR Inks Deal with Canon Virginia

    Vancouver, British Columbia--(Newsfile Corp. - August 8, 2017) - CVR Global Inc., on behalf of CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical"), has signed a letter of intent with Canon Virginia, Inc. (CVI), Canon U.S.A., Inc.'s domestic manufacturing subsidiary, for the manufacturer of CVR's Carotid Stenotic Scan (CSS). The CSS is a device being developed for early detection of carotid arterial health, a leading indicator of Stroke.CVR's pairing with ...

  • CVR Medical Announces Independent Report on Clinical Trial Results from Thomas Jefferson University Hospital
    Newsfile6 months ago

    CVR Medical Announces Independent Report on Clinical Trial Results from Thomas Jefferson University Hospital

    Vancouver, British Columbia--(Newsfile Corp. - June 29, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to announce that Thomas Jefferson University Hospital — Jefferson Clinical Research Institute has issued an initial trial report, summarizing the clinical trial progress of the Carotid Stenotic Scan (CSS) under the supervision of Principal Investigator Dr. David Whellan MD, MHS, FACC, FAHA. Dr. Whellan commented, "The ENTICES (Evaluation of a Novel ...

  • Newsfile7 months ago

    CVR Medical Announces Issuance of Shares for Services

    Vancouver, British Columbia--(Newsfile Corp. - June 2, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to announce that CVR Medical has obtained TSX Venture Exchange approval to issue 243,850 common shares of CVR Medical at a deemed price of $0.3375 per share (the "Shares"), as payment to the Lubow Group that was due for their consulting services pursuant to a consulting agreement with an effective date of January ...

  • Newsfile7 months ago

    CVR Installs Additional CSS Devices at Thomas Jefferson University and Expands Enrollment Base

    Vancouver, British Columbia--(Newsfile Corp. - May 25, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to announce an update of its clinical trials of the "Carotid Stenotic Scan (CSS)," being conducted through the Jefferson Clinical Research Institute at Thomas Jefferson University under the supervision of Dr. David J. Whellan.Tertiary clinical trials have now been underway for four months at multiple site locations across the Thomas Jefferson University footprint. ...

  • Accesswire7 months ago

    CVR Medical Announces Share Issuance for Services

    VANCOUVER, BC / ACCESSWIRE / May 12, 2017 / CVR Medical Corp. (TSX-V: CVM ) (FSE: B3BN) (OTCQB: CRRVF) (" CVR Medical ") had entered into a consulting agreement with Lubow Group ("Lubow"), ...

  • Accesswire8 months ago

    CVR Medical Provides Update on its Thomas Jefferson University Clinical Trials

    VANCOUVER, BC / ACCESSWIRE / April 25, 2017 / CVR Medical Corp. ( TSXV: CVM ) (" CVR Medical ") announces update on clinical trials of the "Carotid Stenotic Scan (CSS)," currently being ...

  • Accesswire8 months ago

    CVR Medical Announces Closing of Second Tranche of Financing

    VANCOUVER, BC / ACCESSWIRE / April 24, 2017 / CVR Medical Corp. (TSX-V: CVM ) (FSE: B3BN) (OTCQB: CRRVF) (" CVR Medical ") is pleased to report that it has closed the second and final tranche ...

  • Accesswire8 months ago

    CVR Medical Announces Closing of First Tranche of Financing

    VANCOUVER, BC / ACCESSWIRE / April 20, 2017 / CVR Medical Corp. (TSXV: CVM ) (FSE: B3BN) (OTCQB: CRRVF) (" CVR Medical ") is pleased to report that it has closed the first tranche (the " ...

  • Accesswire9 months ago

    CVR Medical Announces Amended Financing Price

    VANCOUVER, BC / ACCESSWIRE / March 29, 2017 / CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) (" CVR Medical ") previously announced its intention to complete a private placement financing ...

  • Accesswire9 months ago

    CVR Medical Announces Proposed $5M Institutionally Led Financing

    VANCOUVER, BC / ACCESSWIRE / March 20, 2017 / CVR Medical Corp. (TSXV: CVM ) (FSE: B3BN) (OTCQB: CRRVF) (" CVR Medical ") a leading research and development company aiming to make arterial diagnostic ...

  • Oilprice.com9 months ago

    5 Biotech Companies Set for Major Breakouts In 2017

    5 Biotech Companies Set for Major Breakouts In 2017

  • Accesswire9 months ago

    CVR Medical Teams with Tech Manufacturer ADCO Circuits

    VANCOUVER, BC / ACCESSWIRE / March 16, 2017 / CVR Medical Corp. (TSX-V: CVM ) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces partnership with ADCO Circuits, a Michigan-based electronic ...

  • Oilprice.com9 months ago

    The Most Promising Biotech Innovation Of 2017

    A little-known biotech company is on the verge of launching a device that may help prevent strokes, and possibly save millions of lives and billions of dollars

  • Accesswire9 months ago

    CVR Medical Announces Cancellation of Warrant Acceleration Terms

    VANCOUVER, BC / ACCESSWIRE / March 13, 2017 / CVR Medical Corp. (TSXV: CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (" CVR Medical ") is pleased to announce today that it has cancelled and will not ...

  • Oilprice.com9 months ago

    Could This Be One Of The Biggest Biotech Breakthroughs Of The Decade?

    A little-known biotech company is on the verge of launching a device that may help prevent death and debilitation by detecting the leading indicator of stroke

  • Accesswire9 months ago

    CVR Medical Announces Letter of Intent to Acquire Additional Interest

    VANCOUVER, BC / ACCESSWIRE / March 9, 2017 / CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) (" CVR Medical ") is pleased to report that it has entered into a letter of intent with CVR ...

  • Accesswire10 months ago

    CVR Medical Announces Financing Closing

    VANCOUVER, BC / ACCESSWIRE / February 23, 2017 / CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) (" CVR Medical ") is pleased to report that it has closed its previously announced non-brokered ...